MDWD: MediWound Ltd. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 190.77
Enterprise Value ($M) 184.29
Book Value ($M) 34.23
Book Value / Share 3.17
Price / Book 5.57
NCAV ($M) 13.39
NCAV / Share 1.24
Price / NCAV 14.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.89

Liquidity (mrq)
Quick Ratio 1.99
Current Ratio 2.11

Balance Sheet (mrq) ($M)
Current Assets 53.89
Assets 74.73
Liabilities 40.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-11 13G/A Rosalind Advisors, Inc.
11-14 13G/A Point72 Asset Management, L.P. 0.10 -98.57
10-01 13G Yelin Lapidot Holdings Management Ltd. 6.96 96.55
07-19 13D/A Access Industries Holdings LLC 13.80
07-19 13D Molnlycke Health Care AB 8.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 18,888 79,417 23.78
2025-02-21 7,678 19,552 39.27
2025-02-20 9,334 50,138 18.62
2025-02-19 5,854 16,459 35.57

(click for more detail)

Similar Companies
LNTH – Lantheus Holdings, Inc. LRMR – Larimar Therapeutics, Inc.
LXEO – Lexeo Therapeutics, Inc. MIRM – Mirum Pharmaceuticals, Inc.
MNKD – MannKind Corporation


Financial data and stock pages provided by
Fintel.io